Building and leading a startup can come with a special set of problems and barriers. How do the most successful entrepreneurs navigate decisions around funding, strategic direction, growth, commercialization, and more? What have serial entrepreneurs figured out about the startup environment that others have missed? What strategies do serial entrepreneurs employ that have resulted in success, time after time?
Â
Join Kate Merton, Head of JLABS @ NYC, as she moderates a dynamic discussion between two top serial entrepreneurs to get their perspectives on lessons learned, tips and tricks, and recommendations for current startups who are looking toward successful commercialization.
.
As Head of Johnson & Johnson Innovation, JLABS in New York, Kate is responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and P&L. She catalyzes and supports the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device, consumer and healthtech sectors.
Kate holds an undergraduate degree in Pharmacology & Toxicology from King’s College London, and a PhD in Pharmacology & Toxicology from University of California, Irvine Medical School. She received her MBA from the Fuqua School of Business at Duke University.
Venk is the co-founder and CEO of Nanowear, a New York-based connected-self technology platform for non-invasive diagnostics and digital therapeutics built upon first-of-its-kind cloth-based nanosensors. Nanowear was founded in September 2014 and received its first FDA 510(k) Class II clearance in December 2016 establishing Nanowear as the first-and-only company in the world to receive this accreditation for cloth-based cardiac remote monitoring. Nanowear’s first product, SimpleSense, is an undergarment that captures and algorithmically scores 7 metrics from the body, alerting hospital providers of worsening Heart Failure ~3 weeks in advance of a hospitalizing event. Nanowear’s business model centers around its CHF digital therapeutic device and select licensing opportunities of its cloth-based nanosensors to Healthcare OEMs.
Josh Rosenthal, PhD, is a serial entrepreneur with a string of successful exits. He has repeatedly taken startups he co-founded to successful acquisitions with strategic, financial, and publicly-traded acquirers. Named an Ernst and Young EY Entrepreneur of the Year, his work with has won praise in Entrepreneur Magazine, Forbes, Bloomberg, & US News. At Narwhal Ventures he invests in early-stage companies, working closely with startups through a curriculum and resources with partners and previous co-founders Melanie Rosenthal and Burak Sezen at the 6ixth Event.
Â
Josh received a Fulbright to the Sorbonne’s Institute for Advanced Studies (EPHE). A guest lecturer/speaker in entrepreneurship at Harvard, Hopkins, MIT, SXSW, he has been featured on NPR with the CTO of the United States. He has served as private sector expert on congressionally-appointed government committees (ONC, HHS, NCHVS) for data, analytics, and entrepreneurship and was named a CMS Innovator. Co-founder & CSO of Sprigley with Melanie Rosenthal and Burak Sezen [Acquired by Eliza, 2009]. Deal team for Eliza [majority stake investment by Parthenon Capital, 2011]. Co-founder & CSO of RowdMap, Inc. with Melanie and Burak [Acquired by Cotiviti (COTV), 2017].
Â
-
